PROVIDER PROFILE · NPI 1033127477
Mary Burgess-Parker
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
130
Beneficiaries
—
Total drug cost
$35K
Distinct drugs
7
Brand share
30.0%
Top prescribed drugs
Albuterol Sulfate25 claims
Amlodipine Besylate23 claims
Losartan Potassium20 claims
Rosuvastatin Calcium20 claims
Metformin Hcl17 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$31
Payment records
1
By payment type
Food and Beverage$31
Top paying entities
Food and Beverage$31
REFERRAL NETWORK
Where Mary Burgess-Parker's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 23 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| JANDER, HARTWIG | 26 | 47 |
| GADSDEN REGIONAL MEDICAL CENTER LLC | 21 | 42 |
| MONTIEL, DAVID | 18 | 22 |
| Radwan Mallah Hospitalist · Gadsden, AL | 14 | 25 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| RIVERVIEW REGIONAL MEDICAL CENTER LLC | 68 | 208 |
| JANDER, HARTWIG | 54 | 141 |
| GADSDEN REGIONAL MEDICAL CENTER LLC | 33 | 72 |
| PRIME HEALTHCARE SERVICES - GADSDEN LLC | 22 | 74 |
| Radwan Mallah Hospitalist · Gadsden, AL | 21 | 27 |
| Virenjan Narayan Cardiology · Gadsden, AL | 21 | 50 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL | 20 | 37 |
| Thomas Harrell Interventional Radiology · Birmingham, AL | 19 | 40 |
| TOWN OF ALTOONA | 14 | 27 |
| Vicente Torregosa Internal Medicine · Gadsden, AL | 14 | 47 |
| Homer Spencer Diagnostic Radiology · Gadsden, AL | 14 | 33 |
| Bankimchandra Patel Cardiology · Gadsden, AL | 13 | 27 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE